1. Home
  2. MUC vs SPRY Comparison

MUC vs SPRY Comparison

Compare MUC & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MUC
  • SPRY
  • Stock Information
  • Founded
  • MUC 1997
  • SPRY 2015
  • Country
  • MUC United States
  • SPRY United States
  • Employees
  • MUC N/A
  • SPRY N/A
  • Industry
  • MUC Investment Bankers/Brokers/Service
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • MUC Finance
  • SPRY Health Care
  • Exchange
  • MUC Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • MUC 971.0M
  • SPRY 1.6B
  • IPO Year
  • MUC N/A
  • SPRY N/A
  • Fundamental
  • Price
  • MUC $10.40
  • SPRY $16.95
  • Analyst Decision
  • MUC
  • SPRY Strong Buy
  • Analyst Count
  • MUC 0
  • SPRY 4
  • Target Price
  • MUC N/A
  • SPRY $28.75
  • AVG Volume (30 Days)
  • MUC 292.8K
  • SPRY 1.5M
  • Earning Date
  • MUC 01-01-0001
  • SPRY 08-05-2025
  • Dividend Yield
  • MUC 4.19%
  • SPRY N/A
  • EPS Growth
  • MUC N/A
  • SPRY N/A
  • EPS
  • MUC N/A
  • SPRY N/A
  • Revenue
  • MUC N/A
  • SPRY $97,122,000.00
  • Revenue This Year
  • MUC N/A
  • SPRY N/A
  • Revenue Next Year
  • MUC N/A
  • SPRY $140.40
  • P/E Ratio
  • MUC N/A
  • SPRY N/A
  • Revenue Growth
  • MUC N/A
  • SPRY 971120.00
  • 52 Week Low
  • MUC $9.19
  • SPRY $8.77
  • 52 Week High
  • MUC $11.30
  • SPRY $18.90
  • Technical
  • Relative Strength Index (RSI)
  • MUC 57.36
  • SPRY 55.33
  • Support Level
  • MUC $10.25
  • SPRY $15.75
  • Resistance Level
  • MUC $10.39
  • SPRY $18.90
  • Average True Range (ATR)
  • MUC 0.09
  • SPRY 1.04
  • MACD
  • MUC 0.02
  • SPRY 0.01
  • Stochastic Oscillator
  • MUC 91.30
  • SPRY 49.26

About MUC Blackrock MuniHoldings California Quality Fund Inc.

BlackRock MuniHoldings California Quality Fund Inc is a diversified, closed-end management investment firm. The investment objective of the company is to provide shareholders with current income exempt from U.S. federal income taxes and California personal income taxes.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: